UK firm begins stem cell trial
LONDON – BRITISH biotechnology company ReNeuron and a team of doctors in Scotland have won final approval to start a pioneering clinical trial to assess whether stem cell therapy can help patients disabled by stroke. The treatment involves injecting neural stem cells developed from human foetus into patients’ brains in the hope they will repair areas damaged by stroke, thereby improving both …
[Read the full article here]Related News:
First stem cell trial for stroke patients begins
British Biotech Company To Begin Stem Cell Trials
Pioneering Stem Cell Trial Passes Safety Test